GHK-Cu: Extracellular Matrix Remodeling and Angiogenesis GHK-Cu (glycine-L-histidine-L-lysine complexed with copper II) is a naturally occurring tripeptide-metal complex first isolated from human plasma by Loren Pickart in 1973
The major limiting step to achieving normoglycaemia is hypoglycaemia, which occurs more frequently in the first half of pregnancy, in part because of diminished awareness of hypoglycaemia and pregnancy-associated nausea and vomiting [267]
In writing about her own experience in using the medicine to help her shed 40 pounds, Washington Post columnist Ruth Marcus in June noted that Novo Nordisk mentioned the potential for weight loss in its ubiquitous cable ads (Oh-oh-oh, Ozempic!) The American Society of Health-System Pharmacists has reported shortages of semaglutide due to demand, leaving some people with diabetes struggling to find supply of the medicine
The head-to-head SURMOUNT-5 trial, published in the New England Journal of Medicine in 2025, found tirzepatide produced about 20% body weight loss versus about 14% for semaglutide over 72 weeks
Semaglutide has reshaped the diabetes and weight-loss landscape